News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GammaCan International, Inc. (GCAN.OB) to Present at the Rodman & Renshaw 9th Annual Healthcare Conference 2007


11/5/2007 9:46:32 AM

KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--GammaCan International, Inc. (“GammaCan” or “the Company”) (OTCBB: GCAN), a developer of proprietary immunotherapies for the treatment of melanoma and other cancers, announced that Steven Katz, Chairman of the Board and President, will present an overview of the Company at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New York City. GammaCan’s presentation to the investment community will take place on:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES